Eva
Poveda López
Hospital Universitario San Cecilio
Granada, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario San Cecilio (19)
2019
-
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 3, pp. 195-202
-
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice
The Journal of antimicrobial chemotherapy, Vol. 74, Núm. 6, pp. 1693-1700
2017
-
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study
HIV Medicine, Vol. 18, Núm. 7, pp. 482-489
-
Minimizing next-generation sequencing errors for HIV drug resistance testing
AIDS Reviews, Vol. 19, Núm. 4, pp. 231-238
2015
-
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
-
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194
2013
-
Resistencia a telaprevir
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. SUPPL.3, pp. 26-32
-
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies
AIDS, Vol. 27, Núm. 1, pp. 81-85
2012
-
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
Retrovirology, Vol. 9
-
Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists
AIDS Reviews, Vol. 14, Núm. 3, pp. 208-217
2011
-
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients
AIDS, Vol. 25, Núm. 6, pp. 761-766
-
Methods for determination of HIV tropism and their clinical use
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. SUPPL. 5, pp. 45-50
2010
-
Drug resistance mutations in HIV-infected patients in the Spanish drug resistance database failing tipranavir and darunavir therapy
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 3018-3020
-
Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database
AIDS, Vol. 24, Núm. 3, pp. 469-471
-
Genotypic determination of HIV tropism - Clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists
AIDS Reviews, Vol. 12, Núm. 3, pp. 135-148
2009
-
Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists
Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 5, pp. 1006-1010
-
Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools
Journal of Medical Virology, Vol. 81, Núm. 5, pp. 763-767
2008
-
Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes
Journal of Clinical Microbiology, Vol. 46, Núm. 3, pp. 887-891